CS logo
small CS logo
Elblandklinikum Riesa

Riesa, Germany
University hospital in Riesa, Saxony
Weinbergstraße 8, 01589 Riesa

About Elblandklinikum Riesa


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
AIO-Studien-gGmbH
1
Ipsen
1
Janssen Research & Development, LLC
1
Leipzig Heart Institute GmbH
1
Straub Medical AG
1
Total Rows: 6

Clinical Trials at Elblandklinikum Riesa


During the past decade, Elblandklinikum Riesa conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000033330000000000Started TrialsCompleted Trails2015201620172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
2015-03-01
2020-08-01
Completed
64
2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
2018-03-31
2023-05-30
Active, not recruiting
270
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
2018-09-01
2023-02-21
Terminated
959
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
2018-09-24
2026-08-31
Recruiting
105
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
2019-08-01
2022-09-19
Completed
3,679
Post-Market Clinical Follow Up of Rotarex®S Catheter
2019-07-17
2022-10-26
Completed
220
PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer
2019-10-24
2029-01-01
Active, not recruiting
471

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Elblandklinikum Riesa" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Leipzig Heart Institute GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Elblandklinikum Riesa" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Servier Deutschland GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstitut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 2Institut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 2AIO-Studien-gGmbH: 1AIO-Studien-gGmbH: 1Ipsen: 1Ipsen: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Leipzig Heart Institute GmbH: 1Leipzig Heart Institute GmbH: 1Straub Medical AG: 1Straub Medical AG: 1

Created with Highcharts 11.1.0Top CollaboratorsCelgene: 1Celgene: 1Crolll Gmbh: 1Crolll Gmbh: 1Heart Center Leipzig -University Hospital: 1Heart Center Leipzig -University Hospital: 1Servier Deutschland GmbH: 1Servier Deutschland GmbH: 1

Clinical Trials Conditions at Elblandklinikum Riesa


According to Clinical.Site data, the most researched conditions in "Elblandklinikum Riesa" are "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Chronic Heart Failure" (1 trials), "Locally Advanced Pancreatic Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Metastatic Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Elblandklinikum Riesa" in a lesser frequency.

Clinical Trials Intervention Types at Elblandklinikum Riesa


Most popular intervention types in "Elblandklinikum Riesa" are "Drug" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "Atherectomy/Thrombectomy" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "FerInject" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Elblandklinikum Riesa


The vast majority of trials in "Elblandklinikum Riesa" are 7 trials for "All" genders.

Clinical Trials Status at Elblandklinikum Riesa


Currently, there are NaN active trials in "Elblandklinikum Riesa". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Elblandklinikum Riesa, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Elblandklinikum Riesa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1